Newsroom

TOKYO & BASKING RIDGE, N.J.--(BUSINESS WIRE)--DESTINY-Endometrial02 Phase 3 Trial of ENHERTU® Initiated as Adjuvant Therapy in Patients with HER2 Expressing Endometrial Cancer...

ROME--(BUSINESS WIRE)--Regulatory News: Mexedia S.p.A. Società Benefit (Euronext Growth Paris : ALMEX, ISIN IT0005450819) (« Mexedia » ou la « Société ») informe que le rapport de couverture analyste préparé par GBC AG – l’un des principaux cabinets indépendants de recherche financière en Allemagne –, élaboré dans le cadre d’une issuer-sponsored research, a été finalisé et est désormais publiquement disponible. Ce rapport fait suite à la reprise de la couverture analyste par GBC AG, précédemmen...

ROMA--(BUSINESS WIRE)--Mexedia S.p.A. Società Benefit (Euronext Growth Paris: ALMEX, ISIN IT0005450819) (“Mexedia” o la “Società”) comunica che il report di analyst coverage predisposto da GBC AG – una delle principali società indipendenti di ricerca finanziaria in Germania –, sviluppato nell’ambito di un contesto di issuer-sponsored research, è stato completato ed è ora pubblicamente disponibile. Il report fa seguito alla riattivazione della copertura da parte di GBC AG, precedentemente comuni...

ROME--(BUSINESS WIRE)--Regulatory News: Mexedia S.p.A. Società Benefit (Euronext Growth Paris: ALMEX, ISIN IT0005450819) (“Mexedia” or the “Company”) informs that the analyst coverage report prepared by GBC AG – one of the leading independent financial research firms in Germany –, developed within an issuer-sponsored research framework, has been completed and is now publicly available. The report follows the re-initiation of analyst coverage by GBC AG previously communicated by the Company and...

TOKYO & BASKING RIDGE, N.J.--(BUSINESS WIRE)--ENHERTU® Granted Breakthrough Therapy Designation in the U.S. as Post-Neoadjuvant Therapy for Patients with HER2 Positive Early Breast Cancer...

新加坡--(BUSINESS WIRE)--(美國商業資訊)-- 全球首屈一指的技術和資料供應商Intercontinental Exchange (NYSE:ICE)今日宣布，Nanhua Singapore Pte. Ltd. (Nanhua Singapore)已正式成為ICE Futures Singapore和ICE Clear Singapore的會員。憑藉這一雙重會員資格，Nanhua Singapore可展開自營業務和客戶業務的交易及結算操作。 Nanhua Singapore執行長Zheng Peiyuan表示：「我們欣然加入新加坡的ICE平台，成為會員後，Nanhua Singapore得以強化自身的交易和全球結算能力，為客戶擴大國際市場的投資機會。這一會員資格彰顯了我們對於提供可靠高效的服務、滿足客戶不斷變化的需求的承諾，我們期待在持續協助客戶實現全球業務成長的同時，深化與ICE的合作。」 ICE Futures Singapore和ICE Clear Singapore總裁兼營運長Maria Levanti表示：「我們欣然歡迎Nanhua Singapore加入...

新加坡--(BUSINESS WIRE)--(美国商业资讯)-- 全球领先的技术和数据提供商Intercontinental Exchange (NYSE:ICE)今日宣布，Nanhua Singapore Pte. Ltd. (Nanhua Singapore)已正式成为ICE Futures Singapore和ICE Clear Singapore的会员。凭借这一双重会员资格，Nanhua Singapore可开展自营业务和客户业务的交易及清算操作。 Nanhua Singapore首席执行官Zheng Peiyuan表示：“我们很高兴能加入新加坡的ICE平台，成为会员后，Nanhua Singapore得以强化自身的交易和全球清算能力，为客户拓展国际市场的投资机遇。这一会员资格彰显了我们对于提供可靠高效的服务、满足客户不断变化的需求的承诺，我们期待在持续助力客户实现全球业务增长的同时，深化与ICE的合作。” ICE Futures Singapore和ICE Clear Singapore总裁兼首席运营官Maria Levanti表示：“我们非常高兴欢迎Nanhua Singa...

LONDON--(BUSINESS WIRE)--  19-December-2025 Issue: Mitsubishi HC Capital UK Plc Series 952 XS3185370544 Pursuant to our appointment as Agent for the above stated issue, please be advised of the following interest rate determination: Date From: 24-September-2025 Date To: 24-December-2025 Record Date: 23-December-2025 Value Date: 24-December-2025 Benchmark Rate: 4.08622% Margin: 0.95% Total Rate: 5.03622% Floor: 0% Number of Days: 90 Day Count: 30/360 (ICMA) Basic Rule Interest Frequency: Quarter...

LONDON--(BUSINESS WIRE)--  Pershing Square Holdings, Ltd. Announces Transactions in Own Shares - 19 December 2025 Pershing Square Holdings, Ltd. (LN:PSH) (LN:PSHD) (“PSH”) today announced that it has purchased, through PSH’s agent, Jefferies International Limited (“Jefferies”), the following number of PSH’s Public Shares of no par value (ISIN Code: GG00BPFJTF46) (the "Shares"): Total Buyback   Ticker/s: PSH (LSE); PSHD (LSE) Date of Purchase: 19 December 2025 Number of Public Shares Purchased:...

LONDON--(BUSINESS WIRE)--  22 December 2025 YOUNG & CO.’S BREWERY, P.L.C. Transaction in own shares Young & Co.’s Brewery, P.L.C. (the “Company”) announces that on 19 December 2025, in accordance with the terms of its share buyback programme announced by the Company on 17 November 2025 (the “Share Buyback Programme”), it has purchased the following Non-voting ordinary shares of 12.5 pence each (“Non-voting Shares” and the “Purchased Shares”) in the Company through Peel Hunt LLP (“Peel H...